GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amarantus Bioscience Holdings Inc (OTCPK:AMBS) » Definitions » Revenue

Amarantus Bioscience Holdings (Amarantus Bioscience Holdings) Revenue : $0.00 Mil (TTM As of Dec. 2015)


View and export this data going back to 2008. Start your Free Trial

What is Amarantus Bioscience Holdings Revenue?

Amarantus Bioscience Holdings's revenue for the six months ended in Dec. 2015 was $0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2015 was $0.00 Mil. Amarantus Bioscience Holdings's Revenue per Share for the six months ended in Dec. 2015 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2015 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Amarantus Bioscience Holdings Revenue Historical Data

The historical data trend for Amarantus Bioscience Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amarantus Bioscience Holdings Revenue Chart

Amarantus Bioscience Holdings Annual Data
Trend Oct08 Oct09 Oct10 Dec11 Dec12 Dec13 Dec14 Dec15
Revenue
Get a 7-Day Free Trial 0.22 - - - -

Amarantus Bioscience Holdings Semi-Annual Data
Oct08 Oct09 Oct10 Dec11 Dec12 Dec13 Dec14 Dec15
Revenue Get a 7-Day Free Trial 0.22 - - - -

Competitive Comparison of Amarantus Bioscience Holdings's Revenue

For the Biotechnology subindustry, Amarantus Bioscience Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amarantus Bioscience Holdings's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amarantus Bioscience Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Amarantus Bioscience Holdings's Revenue falls into.



Amarantus Bioscience Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Revenue for the trailing twelve months (TTM) ended in Dec. 2015 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amarantus Bioscience Holdings  (OTCPK:AMBS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Amarantus Bioscience Holdings Revenue Related Terms

Thank you for viewing the detailed overview of Amarantus Bioscience Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Amarantus Bioscience Holdings (Amarantus Bioscience Holdings) Business Description

Traded in Other Exchanges
N/A
Address
45 Wall Street, Suite 920, New York, NY, USA, 10005
Amarantus Bioscience Holdings Inc is a biopharmaceutical company. It is focused on developing therapeutic products for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company's prime therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia. The group's diagnostics division is dedicated to the development and commercialization of neurology diagnostic products. Its diagnostic product, LymPro Test is a blood-based assay to diagnose Alzheimer's disease.
Executives
Flanigan Conn other: Former Director 1601 BLAKE STREET, SUITE 310, DENVER CO 80202
Robert Edward Farrell officer: CFO BIOVEST INTERNATIONAL, INC., 300 S HYDE PARK AVENUE, SUITE 210, TAMPA FL 33606
Joseph Rubinfeld director C/O SUPERGEN INC, 4140 DUBLIN BLVD STE 200, DUBLIN CA 94568

Amarantus Bioscience Holdings (Amarantus Bioscience Holdings) Headlines

From GuruFocus

Amarantus to Present at The Microcap Conference in NYC

By Marketwired Marketwired 04-09-2018

Cutanogen Appoints Richard Kagan, MD as Chief Medical Advisor

By Marketwired Marketwired 04-23-2018

Top 5 1st Quarter Trades of Anson Funds Management LP

By GuruFocus Research GuruFocus Editor 05-12-2022